Connect with us

/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Goldman Sachs Merchant Banking Division to Acquire Capital Vision Services from Altas Partners and CDPQ

Published

on

Reading Time: 3 minutes

NEW YORK & VIENNA & TORONTO & QUEBEC CITY, Québec–(BUSINESS WIRE)–West Street Capital Partners VII, a fund managed by the Merchant Banking
Division of Goldman Sachs (“GS MBD”), Altas Partners (“Altas”) and
Caisse de dépôt et placement du Québec (“CDPQ”) announced today their
entry into a definitive agreement under which GS MBD will
acquire Capital Vision Services, LP (“CVS”) from Altas and CDPQ.

CVS, which provides management services to MyEyeDr. O.D.’s (“MyEyeDr.”
or the “Company”) optometry practices, supports affiliated independent
MyEyeDr. optometrists and their practices with a complete array of
financial, marketing, human resources, and accounting services, along
with managed care credentialing and claims processing. MyEyeDr.
practices offer patients personalized and essential eye care services,
an unmatched selection of prescription eyeglasses and sunglasses, and
standard and specialty contact lenses to meet their unique vision,
health and wellness needs.

“We are thrilled to partner with GS MBD as we turn to the next chapter
of our growth and champion a new path for eye care,” said Sue Downes,
Co-Founder and CEO of CVS. “GS MBD’s funds have a long and established
track record of successfully scaling healthcare companies, and we look
forward to leveraging their expertise as we provide even more patients
access to the latest in vision care technology.”

“We also thank Altas and CDPQ for their partnership and invaluable
support these last several years,” added Downes. “By leveraging their
operational expertise and strategic insight, we were able to
significantly enhance our capabilities, processes and systems and
strengthen our senior management team with the addition of multiple key
hires.”

“We are very excited to announce this transaction and mark the beginning
of the next chapter of CVS’ success,” said Jo Natauri, Global Head of
Healthcare Investing for the Goldman Sachs Merchant Banking Division.
“We look forward to partnering with this talented management team and
building on their foundation of commercial and operating excellence. CVS
has a proven consumer-directed healthcare model that champions
optometrists and promotes eye health. We are proud to support the
Company’s continued growth and pleased about this new investment, which
expands our portfolio in the healthcare services sector.”

“We are extremely proud to have partnered with Sue Downes, David Sheffer
and the entire CVS management team during this time of tremendous growth
and development for the Company,” said Scott Werry, a Managing Partner
of Altas. “At the time of our investment in 2015, CVS managed 165
practices in 7 states; by the end of this year, the Company’s footprint
will have grown to 575 practices in 18 states nationwide. CVS is well
ahead of schedule in achieving our strategic vision for the business,
which was focused on significantly enhancing its scale and scope while
delivering improved patient outcomes across its affiliated practices.”

“CVS achieved tremendous success in growing the Company during the past
few years. This is now a world-class organization that is poised for
continued growth in the coming years,” said Stéphane Etroy, Executive
Vice-President and Head of Private Equity at CDPQ. “It is a great
experience to work alongside an exceptional management team such as the
one leading CVS and support them with the right mix of strategic input
and tools that enable them to thrive.”

The transaction is expected to close in the third quarter of 2019
subject to customary closing conditions and regulatory approvals.

About Capital Vision Services, LP

Founded in 2001, Capital Vision Services, which provides management
services to full-service optometry practices, is a market leader. Its
affiliated MyEyeDr. practices offer patients exceptional full-service
vision care, a wide selection of prescription eyeglasses and sunglasses,
and standard and specialty contact lenses. Capital Vision Services
provides affiliated, independent optometrists with a complete array of
financial, marketing, human resources and accounting services, along
with managed care credentialing and claims processing.

For more information: https://www.capitalvisionservices.com/

About Goldman Sachs Merchant Banking Division

Founded in 1869, The Goldman Sachs Group, Inc. is a leading global
investment banking, securities and investment management firm. Goldman
Sachs Merchant Banking Division is the primary center for the firm’s
long-term principal investing activity. With nine offices across seven
countries, Goldman Sachs Merchant Banking Division is one of the leading
private capital investors in the world with equity and credit
investments across corporate, real estate and infrastructure strategies.
Since 1986, the group has invested approximately $180 billion of levered
capital across a number of geographies, industries and transaction types.

About Altas Partners

Founded in 2012, Altas Partners is an investment firm with a long-term
orientation focused on acquiring significant interests in high-quality,
market-leading businesses in partnership with outstanding management
teams. The firm manages more than $6 billion on behalf of endowments,
foundations, public pension funds and other institutional investors. The
firm’s past and present portfolio companies include University of St.
Augustine for Health Sciences, Tecta America, Hub International, PADI,
Capital Vision Services, Medforth Global Healthcare Education, and NSC
Minerals.

For more information: http://www.altas.com

About Caisse de dépôt et placement du Québec

Caisse de dépôt et placement du Québec (CDPQ) is a long-term
institutional investor that manages funds primarily for public and
parapublic pension and insurance plans. As at December 31, 2018, it held
CA$309.5 billion in net assets. As one of Canada’s leading institutional
fund managers, CDPQ invests globally in major financial markets, private
equity, infrastructure, real estate and private debt. For more
information, visit cdpq.com,
follow us on Twitter @LaCDPQ or
consult our Facebook or LinkedIn pages.

Contacts

For Goldman Sachs Merchant Banking Division:
Leslie Shribman
U.S.:
+1 (212) 902 5400

For Altas Partners:
Sard Verbinnen & Co.
Julie
Rudnick / Kevin Siegel
U.S.: +1 (212) 687 8080
[email protected]

For
CDPQ:

Cesaltine Gregorio
Senior Advisory Director, Global
Media Relations
+1 212 596 6314
+1 347 241 3248
[email protected]


Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Cannabis

Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III

Published

on

Continue Reading

Humboldt

Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace

Published

on

humboldt-seed-company-partners-with-apollo-green-to-bring-california-cannabis-genetics-to-the-global-marketplace

Apollo Green to distribute Humboldt Seed Company clonal cannabis genetics to Germany, Portugal and Australia

SAN FRANCISCO, April 30, 2024 /PRNewswire/ — Humboldt Seed Company (HSC), California’s leading cannabis seed producer, has announced a partnership with Canadian-based Apollo Green to make eight breeder cuts available to researchers, licensed commercial cultivators and home growers in legal markets worldwide. This first-to-market clonal genetics release is a significant milestone and will expand access to distinctive, high-quality cannabis genetics in both established and emerging global markets including Germany, Portugal and Australia.

The curated, breeder-verified selection includes pioneering triploid genetics, such as OG Triploid and Donutz Triploid alongside the legendary cult classic Blueberry Muffin. Also available are All Gas OG with a THC content of 21% and four high-THC strains in the 30-35% range: Golden Sands, Guzzlerz, Jelly Donutz and Orange Creampop. These selections represent the top .01% from HSC’s extensive California pheno-hunting program.

Exports will begin in May under Apollo Green’s Canadian federal cannabis license. All shipments have Canadian phytosanitary certification, ensuring plants have been inspected, and are clean and free of pests.

“Access for all to quality genetics has been our core focus since the beginning,” said HSC Co-founder and Chief Science Officer, Benjamin Lind. “Our science-based approach to breeding aligns perfectly with Apollo Green’s high standards and we are excited to be able to extend these hand-selected cuts to a wider audience, especially at this pivotal time where we’re seeing positive regulatory changes globally.”

Oisin Tierney, Apollo Green Director of Business Development, said, “California has long been recognized for setting industry standards, and we are proud to play a role in bringing these esteemed genetics to cultivators worldwide. The triploids are especially noteworthy in terms of the unprecedented potential for enhanced plant vigor, higher yields, shorter flowering times and superior returns for solventless extraction.”

About Humboldt Seed Company

Established in 2001, Humboldt Seed Company is a Northern California heritage brand providing quality cannabis genetics to commercial cultivators and home growers in legalized states across the U.S. and international markets including Spain, Canada, Jamaica, South Africa, Colombia, France, Portugal, Greece, the UK, Malta and Thailand. With a focus on environmental and social justice, they combine traditional breeding and modern scientific practices in their strain development program. They have served the cannabis community for over two decades.

For more information visit https://humboldtseedcompany.com/.

About Apollo Green

Licensed since 2019, Apollo Green is Canada’s leader in cannabis genetics. The company’s mission is to provide an ever-growing bank of seeds and clones to medical patients and recreational consumers. Apollo Green provides clean, trusted cannabis seeds and clones, which are backed by the foremost tissue culture technology to reduce risks, costs and time-to-market for licensed producers around the world. Apollo Green is passionate about cannabis genetics. 

For more information visit https://apollogreen.com/.

Media contact
Jaana Prall
[email protected] 

Logo – https://mma.prnewswire.com/media/2328955/Humboldt_Seed_Company_Logo.jpg 

Cision View original content:https://www.prnewswire.co.uk/news-releases/humboldt-seed-company-partners-with-apollo-green-to-bring-california-cannabis-genetics-to-the-global-marketplace-302131618.html

Continue Reading

Cannabis

Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety

Published

on

Continue Reading
Advertisement

Latest news

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania